ÂÜÀòÂÒÂ×

Michael Wallace is a seasoned sales professional with extensive experience in the medical field, currently serving as the Hybrid Therapies Sales Manager at AtriCure, Inc. since June 2020. Demonstrating a strong collaborative approach, Michael has consistently achieved quota attainment across all assigned product portfolios over the last five sales quarters and successfully met yearly sales plans in 2021 and 2023. Prior to AtriCure, Michael held significant roles at Boston Scientific as Principal Territory Sales Manager in Electrophysiology, at Sanofi as Senior Cardiovascular Specialty Sales Professional, and at Pfizer as Principal Institutional Cardiovascular Sales Professional. Michael holds a Bachelor's degree in Biology/Biological Sciences from Bucknell University and has completed Master of Science credits in Genetic Neuroscience and Neurophysiology at Penn State College of Medicine.